Hanlan Liu, Ph.D., MBA

Trailblazer
DISC Type : DI

Senior Scientific Advisor at XinGen, an LLC Consulting Firm

Cambridge, Massachusetts, United States

Overview

Hanlan is a biotech executive with over 20 years of experience in drug development, spanning small molecules to cell therapies. Her expertise covers oncology, immunology, and neurology, with a proven record of advancing programs to market and securing over $200M in venture funding. She holds an MBA from NYU Stern.

Outside of her corporate roles, Hanlan is deeply committed to patient advocacy for rare diseases. She is an active supporter of the Channeling Hope Foundation and participates in fundraising events, such as running half marathons, to support research and awareness for NALCN-associated diseases.

Unique fact: Hanlan connects her professional expertise with personal passion by running marathons to raise funds and awareness for rare disease research.

Personality Overview

Informal

Persuasive

Friendly But Fast

If they come to believe in your value proposition, they will be your champion.  They like to keep things under control. They respond better to a combination of speed and relationship.

Topics They Care About

Rare Disease Research
Her experience as CSO at a rare disease-focused company and recent, passionate advocacy for NALCN-associated diseases highlights this as a key professional and personal interest.
Drug Development Lifecycle
She has extensive experience leading therapeutic programs across multiple modalities, from initial concept all the way through to regulatory approval and market launch.
Biotech Venture Funding
She has a successful history of unlocking significant venture capital, having raised over $200 million to advance biopharma programs.

Media Appearances

Hanlan has no verified media appearances

Work History

6-2025
Senior Scientific Advisor at XinGen, an LLC Consulting Firm
10-2024 - 5-2025
Senior Vice President, Head of Late Research and Nonclinical Development at Be Biopharma
6-2022 - 9-2024
Senior Vice President, Rare Disease and Pipeline Research at Be Biopharma
SAB Member at Sperogenix Therapeutics 曙方医药
1-2021 - 5-2022
Chief Scientific Officer/Chief Development Officer at Sperogenix Therapeutics 曙方医药

Education

6-2023 - 6-2023
Women’s Leadership program from MIT Sloan Executive Education
2000 - 2005
MBA with Distinction from NYU Stern School of Business

More Information

Social Presence :

Prographics :

Exp : 8 Location : Cambridge, Massachusetts, United States Job Level : N/A Designation : Senior Scientific Advisor at XinGen, an LLC Consulting Firm
URL has been copied!

Insights For Selling To Hanlan

During A Call Or A Meeting

DO's

  • Showcase existing customers and use case-studies to grab their attention
  • Build a trustworthy relationship while keeping the product center-stage
  • Give them control of the sales process

DONT's

  • Don’t force involvement of other stakeholders unless it is critical
  • Do not look like someone who doesn’t know what they are talking about
  • Don't make any commitments that you might not be able to fulfill

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Hanlan is

  • Relationship and product conviction matter equally, followed by a sense of achievement.
  • Will you ever get a clear answer from Hanlan

  • If they are not convinced, they will say no albeit in a friendly manner.


Insights For Deal Planning

    How fast (or slow) will Hanlan move?

  • If you earn their trust and they develop faith in the product, they can make decisions quickly.
  • Can Hanlan take some risk or not?

  • They can take risks if necessary.

You And Hanlan

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.